[ad_1]
PetVivo Holdings, a leading provider of medical devices and biomedical therapeutics for animals, will showcase its innovative product, Spryng, at the upcoming American Association of Equine Practitioners convention in Orlando, Florida. Spryng is an intra-articular injectable veterinary medical device that helps manage joint pain in animals. The company’s CEO, John Lai, expressed excitement about the opportunity to present Spryng to equine veterinarians at the convention. Visitors can learn more about Spryng at booth #929 during the event.
PetVivo Holdings is focused on developing and commercializing medical devices and therapeutics for companion animals, with the goal of introducing human therapies for animal treatment. The company’s flagship product, Spryng with OsteoCushion Technology, is designed to manage joint-related afflictions, including osteoarthritis, in cats, dogs, and horses. With a portfolio of 21 patents, PetVivo is committed to providing innovative solutions for animal health.
For more information about PetVivo Holdings and Spryng with OsteoCushion Technology, interested parties can visit the company’s website or contact them directly. PetVivo aims to continue its mission of developing effective and efficient medical treatments for animals, while adhering to disclosure obligations and providing transparency to investors. The company encourages individuals to stay informed about its latest developments and future plans.
Source
Photo credit www.globenewswire.com
